4.1 Article

Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Emerging vaccine nanotechnology: From defense against infection to sniping cancer

Chan Feng et al.

Acta Pharmaceutica Sinica B (2022)

Article Chemistry, Multidisciplinary

Bioinspired magnetic nanocomplexes amplifying STING activation of tumor-associated macrophages to potentiate cancer immunotherapy

Tianliang Li et al.

Summary: This study developed bioinspired magnetic nanocomplexes to enhance antitumor immunogenicity by amplifying the STING-regulated immune cascade of TAMs. The nanocomplexes specifically accumulated at the tumor site and repolarized TAMs into antitumor M1 phenotype, leading to activation of the STING pathway and priming of tumor-specific CTLs. In combination with immune checkpoint blockade therapy, the nanocomplexes effectively inhibited tumor growth and prolonged survival in mouse models, providing new insights for cancer immunotherapy.

NANO TODAY (2022)

Article Pharmacology & Pharmacy

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy

Jiayi Ye et al.

Summary: A bispecific prodrug nanoparticle was engineered to target multiple immune resistance mechanisms in tumor cells and improve cancer immunotherapy. The nanoparticle combines photodynamic therapy (PDT) to induce immunogenic cell death, providing a novel strategy for blocking immune evasion pathways.

ACTA PHARMACEUTICA SINICA B (2022)

Article Chemistry, Multidisciplinary

Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition

Jing Gao et al.

Summary: This study highlights the combination of PD-L1 knockdown and CDK4/6 inhibition as a strategy to promote intratumoral infiltration of CTLs, trigger immune response, and efficiently suppress tumor growth.

CHINESE CHEMICAL LETTERS (2021)

Review Biochemistry & Molecular Biology

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Golnaz Morad et al.

Summary: This passage discusses the unprecedented advances in cancer treatment with immune checkpoint blockade (ICB), highlighting the critical need for insights into factors intrinsic and extrinsic to the host that impact ICB response and toxicity. There has been substantial progress in understanding the impact of host-intrinsic factors and the exposome on host physiology and response to treatment, representing the hallmarks of response, resistance, and toxicity to ICB in current day.
Article Chemistry, Multidisciplinary

Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer

Fang Sun et al.

Summary: The study presents a novel strategy to enhance photoimmunotherapy of pancreatic cancer by provoking T cells activation and overcoming adaptive immune resistance.

ADVANCED SCIENCE (2021)

Article Chemistry, Multidisciplinary

Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer

Fengqi Zhou et al.

Summary: The study introduces a sequential prodrug nanovesicle designed to enhance drug delivery to tumor tissues and reduce immunological resistance of tumor cells. The nanovesicles show promising results in inhibiting tumor growth and suppressing metastasis in mouse models, providing a new approach for chemoimmunotherapy of cancers by overcoming immune evasion through the IFN-gamma-BRD4-PD-L1 axis.

NANO TODAY (2021)

Review Oncology

Broadening horizons: the role of ferroptosis in cancer

Xin Chen et al.

Summary: Ferroptosis is an iron-dependent form of regulated cell death driven by excessive lipid peroxidation, and can be induced by various agents to suppress tumor growth while also potentially triggering inflammation-associated immunosuppression. The extent of ferroptosis's impact on tumor biology and its interactions with other signaling pathways are still under investigation.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer

Qiurong Zhu et al.

Summary: A versatile prodrug nanoparticle for second near-infrared (NIR-II) fluorescence imaging-guided combinatory immunotherapy of colorectal cancer has been reported. The nanoparticles show high intratumoral accumulation and trigger immunogenic cell death of the tumor cells, elicit antitumor immune response in a spatiotemporally controllable manner. The combination of the nanoparticle-based photothermal therapy/chemotherapy with programmed death ligand 1 blockade significantly promotes intratumoral infiltration of cytotoxic T lymphocytes and eradicates CRC tumors.
Review Chemistry, Multidisciplinary

Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer

Weiqi Wang et al.

Summary: Stimuli-activatable nanomedicines show promise in improving cancer immunotherapy by enhancing treatment efficiency and reducing side effects through tumor-specific accumulation, controllable drug release, and combinational therapy. These nanomedicines can target tumor cells, immune cells, or peripheral immune systems to elicit sustained systemic immune activation and modulate the immunosuppressive tumor microenvironment.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Oncology

Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer

Milena Hornburg et al.

Summary: This study provides a detailed analysis of distinct T cell infiltration patterns in ovarian tumors, revealing the impact on responses to cancer immunotherapies and the underlying key determinants and biology of tumor immune phenotypes. The research highlights potential molecular mechanisms shaping these phenotypes and may inform therapeutic strategies for enhancing clinical benefit from cancer immunotherapies.

CANCER CELL (2021)

Article Chemistry, Multidisciplinary

Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD-L1 Expression for Circumventing Immune Resistance of Cancer

Fengqi Zhou et al.

Summary: This research addresses the issue of immune evasion in T-cell-based cancer immunotherapy by developing a multifunctional prodrug nanovesicle. By enhancing tumor antigen presentation and the infiltration of T lymphocytes, the prodrug nanovesicles demonstrate efficacy in overcoming immune resistance and potentiate tumor immunotherapy.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer

Rundi Song et al.

Summary: Researchers have developed a immunotherapy method that enhances the immunogenicity of tumor cells by inducing ferroptosis, thereby improving the efficacy of cancer immunotherapy.

ADVANCED MATERIALS (2021)

Review Chemistry, Multidisciplinary

From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer

Madiha Saeed et al.

Summary: This article discusses how nanotechnology-based methods can promote anti-tumor immune responses, with a focus on the importance of normalizing the tumor immune microenvironment. By targeting immunosuppressive cells and signaling pathways, nanomedicine has the potential to enhance the impact of cancer immunotherapy.

ADVANCED MATERIALS (2021)

Review Oncology

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

Suchit Jhunjhunwala et al.

Summary: This review discusses the importance of antigen presentation in the success of immune checkpoint inhibition therapy and mechanisms by which tumors evade immune recognition. Tumors evade immune recognition by modulating antigen expression and altering antigen presentation.

NATURE REVIEWS CANCER (2021)

Review Chemistry, Multidisciplinary

Dynamic covalent chemistry-regulated stimuli-activatable drug delivery systems for improved cancer therapy

Qiwen Zhu et al.

CHINESE CHEMICAL LETTERS (2020)

Review Immunology

Top 10 Challenges in Cancer Immunotherapy

Priti S. Hegde et al.

IMMUNITY (2020)

Review Chemistry, Multidisciplinary

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy

Jing Gao et al.

ACTA PHARMACOLOGICA SINICA (2020)

Review Chemistry, Multidisciplinary

Engineering Prodrug Nanomedicine for Cancer Immunotherapy

Bin Yang et al.

ADVANCED SCIENCE (2020)

Review Immunology

Tumour-intrinsic resistance to immune checkpoint blockade

Anusha Kalbasi et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang et al.

NATURE (2019)

Article Chemistry, Multidisciplinary

Recent Progress in Ferroptosis Inducers for Cancer Therapy

Chen Liang et al.

ADVANCED MATERIALS (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Oncology

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Sattva S. Neelapu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Chemistry, Multidisciplinary

Emerging Strategies of Cancer Therapy Based on Ferroptosis

Zheyu Shen et al.

ADVANCED MATERIALS (2018)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Editorial Material Oncology

Inhibition of TGFβ enhances immune-checkpoint blockade

Diana Romero

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Multidisciplinary Sciences

The Cancer Immunotherapy Revolution

Priscilla N. Kelly

SCIENCE (2018)

Review Oncology

Classifying Cancers Based on T-cell Infiltration and PD-L1

Michele W. L. Teng et al.

CANCER RESEARCH (2015)

Review Chemistry, Multidisciplinary

Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)

Ulrich Laechelt et al.

CHEMICAL REVIEWS (2015)

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Immunology

Innate and adaptive immune cells in the tumor microenvironment

Thomas F. Gajewski et al.

NATURE IMMUNOLOGY (2013)

Article Cell Biology

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

Stefani Spranger et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Review Immunology

Regulatory T Cells: Mechanisms of Differentiation and Function

Steven Z. Josefowicz et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Review Immunology

Towards a systems understanding of MHC class I and MHC class II antigen presentation

Jacques Neefjes et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Review Genetics & Heredity

Progress and problems with the use of viral vectors for gene therapy

CE Thomas et al.

NATURE REVIEWS GENETICS (2003)